Continuing story · 1 report
The ChAdOx1 BDBV Phase I vaccine trial
Gone quiet since
Where it stands
The Phase I safety study began with the first volunteer receiving a dose of ChAdOx1 BDBV in England on July 24, 2026. The study plans to enroll 50 healthy adults; enrollment, safety monitoring and results remain open, and the report gives no date for a next step.
Story trackerDay 1
1 report9 outlets11 sources1 video
The story so far
Update 1
First Bundibugyo Ebola Vaccine Enters Human Arm as Outbreak Toll Tops 1,000
Oxford gave the first Bundibugyo Ebola vaccine dose on 24 July as Central Africa's death toll passed 1,000 — with the exact count still disputed.
Still open after this report
- No verified final case and death counts, volunteer identity, or verbatim leadership quotes in provided sources.
- No confirmed WHO emergency declaration wording or results date in provided sources.
History
Opened1 report
Who's involved
People
Richard HatchettAmerican epidemiologist1 report
Places
- Democratic Republic of the CongoDemocratic Republic of the Congo1 report
- OxfordOxford, UK1 report
- UgandaUganda1 report
Every outlet we read on this story
11 sources9 outlets1 video1 wire copy
Oxford Law Blogsox.ac.uk3
- First volunteer vaccinated in the world's first Bundibugyo ebolavirus vaccine trial — Oxford Vaccine Group
- First volunteer vaccinated in the world's first Bundibugyo ebolavirus vaccine trial — Pandemic Sciences Institute
- World’s first Phase I Bundibugyo ebolavirus vaccine trial launched by Oxford Vaccine Group — Oxford Vaccine Group
Africanewsafricanews.com1
HeyDay News11 video
Medical Xpressmedicalxpress.com1
News Agency of Nigerianannews.ng1
thepharmacist.co.uk1